FT Options’s Insmed INSM Stock Holding History

FT Options’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$560K	Sell	17,953 -5	-0%	-$95	0.84%	41
2017 Q2	$308K	Buy	17,958 +9,483	+112%	+$162K	0.53%	42
2017 Q1	$148K	Buy	+8,475	New	+$131K	0.19%	93

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

FT Options's INSM Position: Q3 2017 in Review

FT Options reduced its Insmed (INSM) stake by 0.03% in Q3 2017, selling an estimated $95 and leaving 17,953 shares worth $560K. The position accounts for 0.84% of the portfolio, ranked #41.

FT Options first reported a position in INSM in Q1 2017 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold INSM as of Q3 2017.

FT Options held 17,953 shares of Insmed worth $560K as of Q3 2017.
FT Options sold 5 Insmed shares in Q3 2017, an estimated $95.
Insmed made up 0.84% of FT Options's portfolio in Q3 2017, its #41 holding.
FT Options first reported a position in Insmed in Q1 2017 and has held it in 3 quarters since.
146 funds tracked by Wall St. Rank held Insmed as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.